| Literature DB >> 28067403 |
Hamed Mirzaei1, Fatemeh Momeni2, Leila Saadatpour3, Amirhossein Sahebkar4, Mohammad Goodarzi5, Aria Masoudifar6, Shirin Kouhpayeh7, Hossein Salehi8, Hamid Reza Mirzaei9, Mahmoud Reza Jaafari10.
Abstract
Stroke is a life-threatening disease that accounts for a considerable burden of mortality in both developing and developed world. Identification of specific biomarkers for stroke and its outcomes can greatly contribute to improved care of patients. MicroRNAs (miRNAs) are known as novel biomarkers that could be used as diagnostic, prognostic, and therapeutic biomarkers. Various studies have shown that miRNAs have key roles in the pathogenesis of stroke, and its complications and outcomes. In addition, there is evidence showing that mesenchaymal stromal cell-derived exosomes containing miRNAs can be used for monitoring and treatment of various diseases such as stroke. Here, we summarized various aspects of miRNA applications in different stages of stroke.Entities:
Keywords: biomarker; exosome; meseanchaymal stromal cell; microRNA; stroke
Mesh:
Substances:
Year: 2017 PMID: 28067403 DOI: 10.1002/jcp.25787
Source DB: PubMed Journal: J Cell Physiol ISSN: 0021-9541 Impact factor: 6.384